10-Year retrospective review of angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) toxic doses in children < 6 years old

被引：0
|
作者：
Pham, Trang [1 ]
Ostrikova, Kim Vo [1 ]
Winter, Mark L. [1 ]
机构：
[1] Southeast Texas Poison Control Ctr, Galveston, TX USA
来源：
CLINICAL TOXICOLOGY | 2023年 / 61卷
关键词：
ACE; ARB;
D O I：
暂无
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
343
引用
收藏
页码：167 / 167
页数：1
相关论文
共 50 条
  • [1] ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS VS ANGIOTENSIN RECEPTOR BLOCKERS (ARB) FOR DIABETIC NEPHROPATHY: A RETROSPECTIVE COMPARISON
    Robles, N. R.
    Romero, B.
    Fernandez Carbonero, E.
    Sanchez Casado, E.
    Cubero, J. J.
    JOURNAL OF HYPERTENSION, 2009, 27 : S85 - S85
  • [2] Pharmacogenetics of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARB) in cardiovascular diseases
    Agostini, Livia da Cunha
    Silva, Nayara Nascimento Toledo
    Belo, Vanessa de Almeida
    Luizon, Marcelo Rizzatti
    Lima, Angelica Alves
    da Silva, Glenda Nicioli
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 981
  • [3] Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and coronavirus
    Verdecchia, Paolo
    Angeli, Fabio
    Reboldi, Gianpaolo
    JOURNAL OF HYPERTENSION, 2020, 38 (06) : 1190 - 1191
  • [4] THE DIFFERENTIAL EFFECT OF ANGIOTENSIN RECEPTOR BLOCKERS (ARB) AND ANGIOTENSIN CONVERTING ENZYME INHIBITORS (ACE) ON LIMB AMPUTATION
    Margolis, David J.
    Hoffstad, Ole
    Crombleholme, Tim
    WOUND REPAIR AND REGENERATION, 2009, 17 (02) : A19 - A19
  • [5] Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers in the Treatment of Hypertension
    Benenson, Irina
    JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2022, 18 (05): : 586 - 587
  • [6] Pneumonia Risk and Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
    Liu, Chia-Lin
    Shau, Wen-Yi
    Chang, Chia-Hsuin
    Wu, Chi-Shin
    Lai, Mei-Shu
    JOURNAL OF EPIDEMIOLOGY, 2013, 23 (05) : 344 - 350
  • [7] Prevention of atrial fibrillation by angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers
    Boos, CJ
    Lip, GYH
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 889 - 890
  • [8] Eczematous reactions due to angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers
    Vena, Gino A.
    Cassano, Nicoletta
    Coco, Valeria
    De Simone, Clara
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2013, 35 (03) : 447 - 450
  • [9] Combined treatment with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: A review of the current evidence
    Tsouli, SG
    Liberopoulos, EN
    Kiortsis, DN
    Mikhailidis, DP
    Elisaf, MS
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2006, 11 (01) : 1 - 15
  • [10] Fracture Risk and Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers
    Holloway-Kew, Kara L.
    Betson, Amelia G.
    Anderson, Kara B.
    Sepetavc, Filip
    Gaston, James
    Kotowicz, Mark A.
    Liao, Wan-Hui
    Henneberg, Maciej
    Pasco, Julie A.
    CALCIFIED TISSUE INTERNATIONAL, 2022, 111 (04) : 396 - 408
12345